Inventor

MATTHIESSEN PETER

AT18 patents

⚠️ This page may combine multiple inventors who share the name “MATTHIESSEN PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MATTHIESSEN PETER

BAXALTA INC

Stabilized liquid and lyophilized ADAMTS13 formulations

Stabilized liquid and lyophilized ADAMTS13 formulations

Stabilized liquid and lyophilized ADAMTS13 formulations

Stabilized liquid and lyophilized ADAMTS13 formulations

Ethanol dependence of alpha1 antitrypsin C-terminal Lys truncation by basic carboxypeptidases

BAXTER INT

Methods for the inactivation of microorganisms in biological fluids, flow through reactors and methods of controlling the light sum dose to effectively inactivate microorganisms in batch reactors

Methods for the inactivation of microorganisms in biological fluids, flow through reactors and methods of controlling the light sum dose to effectively inactivate microorganisms in batch reactors

Method for the purification of alpha-1 proteinase inhibitor (a1PI)

Stabilized liquid and lyophilized ADAMTS13 formulations

Preparative purification process for human furin

MATTHIESSEN PETER

Stabilized liquid and lyophilized ADAMTS13 formulations

Ethanol dependence of alpha1 antitrypsin C-terminal lys truncation by basic carboxypeptidases

Methods for modeling protein stability

TAKEDA PHARMACEUTICALS CO

Recombinant VWF formulations

Stabilized liquid and lyophilized ADAMTS13 formulations

Stabilized liquid and lyophilized ADAMTS13 formulations

BAXTER AG

Stable blood coagulation inhibitor-free factor vii preparation and method for preparing same

ANDERLE HEINZ

Method for the validatable inactivation of pathogens in a biological fluid by irradiation